Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-19 Purchase |
2021-11-23 4:12 pm |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
100 | $6.695 | $670 | 100 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-21 Option Award |
2025-03-25 4:06 pm |
N/A 2035-03-20 |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-12 4:05 pm |
N/A 2034-02-07 |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 08:07 am |
N/A 2033-01-31 |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 7:17 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-12-28 Ownership |
2022-02-10 4:08 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
45 | $0 | 100 (Direct) |
View |
Ownership |
2022-02-10 4:08 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer |
0 | $0 | 100 (Indirect) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:19 pm |
N/A 2031-03-31 |
CATABASIS PHARMACEUTICALS INC | CATB | Komjathy Andrew Chief Commercial Officer |
600,000 | $0 | 600,000 (Direct) |
View |